Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries |
journalArticle |
2015 |
Cain, L. E.; Phillips, A.; Olson, A.; Sabin, C.; Jose, S.; Justice, A.; Tate, J.; Logan, R.; Robins, J. M.; Sterne, J. A.; van Sighem, A.; Reiss, P.; Young, J.; Fehr, J.; Touloumi, G.; Paparizos, V.; Esteve, A.; Casabona, J.; Monge, S.; Moreno, S.; Seng, R.; Meyer, L.; Pérez-Hoyos, S.; Muga, R.; Dabis, F.; Vandenhende, M. A.; Abgrall, S.; Costagliola, D.; Hernán, M. A. |
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis |
journalArticle |
2016 |
De Ruysscher, D.; Lueza, B.; Le Pechoux, C.; Johnson, D. H.; O'Brien, M.; Murray, N.; Spiro, S.; Wang, X.; Takada, M.; Lebeau, B.; Blackstock, W.; Skarlos, D.; Baas, P.; Choy, H.; Price, A.; Seymour, L.; Arriagada, R.; Pignon, J. P.; Group, Rtt-Sclc Collaborative |
Mining the coding and non-coding genome for cancer drivers |
journalArticle |
2015 |
Li, J.; Drubay, D.; Michiels, S.; Gautheret, D. |
Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis |
journalArticle |
2017 |
Blanchard, P.; Belkhir, F.; Temam, S.; El Khoury, C.; De Felice, F.; Casiraghi, O.; Patrikidou, A.; Mirghani, H.; Levy, A.; Even, C.; Gorphe, P.; Nguyen, F.; Janot, F.; Tao, Y. |
Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma |
journalArticle |
2018 |
Brodowicz, T.; Mir, O.; Wallet, J.; Italiano, A.; Blay, J. Y.; Bertucci, F.; Eisterer, W.; Chevreau, C.; Piperno-Neumann, S.; Bompas, E.; Ryckewaert, T.; Liegl-Antzwager, B.; Thery, J.; Penel, N.; Le Cesne, A.; Le Deley, M. C. |
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma |
journalArticle |
2016 |
Gunn, G. B.; Blanchard, P.; Garden, A. S.; Zhu, X. R.; Fuller, C. D.; Mohamed, A. S.; Morrison, W. H.; Phan, J.; Beadle, B. M.; Skinner, H. D.; Sturgis, E. M.; Kies, M. S.; Hutcheson, K. A.; Rosenthal, D. I.; Mohan, R.; Gillin, M. T.; Frank, S. J. |
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients |
journalArticle |
2017 |
Boros, A.; Lacroix, L.; Lacas, B.; Adam, J.; Pignon, J. P.; Caramella, C.; Planchard, D.; de Montpreville, V.; Deutsch, E.; Levy, A.; Besse, B.; Le Pechoux, C. |
Hypofractionation for prostate cancer: a word of caution |
journalArticle |
2016 |
Bossi, A.; Blanchard, P. |
A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials |
journalArticle |
2016 |
Kempf, E.; Lemoine, N.; Tergemina-Clain, G.; Turpin, A.; Postel-Vinay, S.; Lanoy, E.; Soria, J. C.; Massard, C.; Hollebecque, A. |
Cost Of Genome Analysis: The Sanger Sequencing Method |
journalArticle |
2015 |
Perrier, L.; Heinz, D.; Baffert, S.; Zou, Z.; Durand Zaleski, I.; Rouleau, E.; Wang, Q.; Haddad, V.; Bringuier, P.; Merlio, J.; Caumont, C.; Lacroix, L.; Marino, P.; Borget, I. |
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease |
journalArticle |
2016 |
Marthey, L.; Mateus, C.; Mussini, C.; Nachury, M.; Nancey, S.; Grange, F.; Zallot, C.; Peyrin-Biroulet, L.; Rahier, J. F.; Bourdier de Beauregard, M.; Mortier, L.; Coutzac, C.; Soularue, E.; Lanoy, E.; Kapel, N.; Planchard, D.; Chaput, N.; Robert, C.; Carbonnel, F. |
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes |
journalArticle |
2018 |
Frank, S. J.; Pugh, T. J.; Blanchard, P.; Mahmood, U.; Graber, W. J.; Kudchadker, R. J.; Davis, J. W.; Kim, J.; Choi, H.; Troncoso, P.; Kuban, D. A.; Choi, S.; McGuire, S.; Hoffman, K. E.; Chen, H. C.; Wang, X.; Swanson, D. A. |
Dead space closure with quilting suture versus conventional closure with drainage for the prevention of seroma after mastectomy for breast cancer (QUISERMAS): protocol for a multicentre randomised controlled trial |
journalArticle |
2016 |
Ouldamer, L.; Bonastre, J.; Brunet-Houdard, S.; Body, G.; Giraudeau, B.; Caille, A. |
Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients |
journalArticle |
2016 |
Barral, M.; Auperin, A.; Hakime, A.; Cartier, V.; Tacher, V.; Otmezguine, Y.; Tselikas, L.; de Baere, T.; Deschamps, F. |
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers |
journalArticle |
2018 |
Cabel, L.; Fuerea, A.; Lacroix, L.; Baldini, C.; Martin, P.; Hollebecque, A.; Postel-Vinay, S.; Varga, A.; Balheda, R.; Gazzah, A.; Michot, J. M.; Marabelle, A.; Rouleau, E.; Solary, E.; De Baere, T.; Angevin, E.; Armand, J. P.; Michiels, S.; Scoazec, J. Y.; Ammari, S.; André, F.; Soria, J. C.; Massard, C.; Verlingue, L. |
Modalités de surveillance des patients suivis pour un cancer de la prostate avancé : résultats d’une enquête nationale de pratique |
journalArticle |
2016 |
Rozet, F.; Roupret, M.; Hennequin, C.; Massard, C.; Blanchard, P.; Le moulec, S. |
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning |
journalArticle |
2018 |
Klauschen, F.; Müller, K. R.; Binder, A.; Bockmayr, M.; Hägele, M.; Seegerer, P.; Wienert, S.; Pruneri, G.; de Maria, S.; Badve, S.; Michiels, S.; Nielsen, T. O.; Adams, S.; Savas, P.; Symmans, F.; Willis, S.; Gruosso, T.; Park, M.; Haibe-Kains, B.; Gallas, B.; Thompson, A. M.; Cree, I.; Sotiriou, C.; Solinas, C.; Preusser, M.; Hewitt, S. M.; Rimm, D.; Viale, G.; Loi, S.; Loibl, S.; Salgado, R.; Denkert, C. |
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination |
journalArticle |
2016 |
Boutros, C.; Tarhini, A.; Routier, E.; Lambotte, O.; Ladurie, F. L.; Carbonnel, F.; Izzeddine, H.; Marabelle, A.; Champiat, S.; Berdelou, A.; Lanoy, E.; Texier, M.; Libenciuc, C.; Eggermont, A. M.; Soria, J. C.; Mateus, C.; Robert, C. |
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study |
journalArticle |
2017 |
Angevin, E.; Cassier, P. A.; Italiano, A.; Goncalves, A.; Gazzah, A.; Terret, C.; Toulmonde, M.; Gravis, G.; Varga, A.; Parlavecchio, C.; Paci, A.; Poinsignon, V.; Soria, J. C.; Drubay, D.; Hollebecque, A. |
Intramuscular administration of alfaxalone for sedation in rabbits |
journalArticle |
2015 |
Huynh, M.; Poumeyrol, S.; Pignon, C.; Le Teuff, G.; Zilberstein, L. |
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy |
journalArticle |
2018 |
Ferrara, R.; Mezquita, L.; Texier, M.; Lahmar, J.; Audigier-Valette, C.; Tessonnier, L.; Mazieres, J.; Zalcman, G.; Brosseau, S.; Le Moulec, S.; Leroy, L.; Duchemann, B.; Lefebvre, C.; Veillon, R.; Westeel, V.; Koscielny, S.; Champiat, S.; Ferte, C.; Planchard, D.; Remon, J.; Boucher, M. E.; Gazzah, A.; Adam, J.; Bria, E.; Tortora, G.; Soria, J. C.; Besse, B.; Caramella, C. |
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France |
journalArticle |
2015 |
Scotte, F.; Martelli, N.; Vainchtock, A.; Borget, I. |
Treatment of squamous cell carcinoma of the posterior pharyngeal wall: Radiotherapy versus surgery |
journalArticle |
2016 |
De Felice, F.; Blanchard, P.; Levy, A.; Nguyen, F.; Gorphe, P.; Janot, F.; Temam, S.; Tao, Y. |
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours |
journalArticle |
2015 |
Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X. |
Burnout among young European oncologists: a call for action |
journalArticle |
2017 |
Blanchard, P. |
Ewing's Sarcoma of the Head and Neck: Margins are not just for surgeons |
journalArticle |
2018 |
Bouaoud, J.; Temam, S.; Cozic, N.; Galmiche-Rolland, L.; Belhous, K.; Kolb, F.; Bidault, F.; Bolle, S.; Dumont, S.; Laurence, V.; Plantaz, D.; Tabone, M. D.; Marec-Berard, P.; Quassemyar, Q.; Couloigner, V.; Picard, A.; Gomez-Brouchet, A.; Le Deley, M. C.; Mahier-Ait Oukhatar, C.; Kadlub, N.; Gaspar, N. |
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer |
journalArticle |
2016 |
Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P. |
Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience |
journalArticle |
2016 |
Bluthgen, M. V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B. |
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report |
journalArticle |
2016 |
Kager, L.; Whelan, J.; Dirksen, U.; Hassan, B.; Anninga, J.; Bennister, L.; Bovee, Jvmg; Brennan, B.; Broto, J. M.; Brugieres, L.; Cleton-Jansen, A. M.; Copland, C.; Dutour, A.; Fagioli, F.; Ferrari, S.; Fiocco, M.; Fleuren, E.; Gaspar, N.; Gelderblom, H.; Gerrand, C.; Gerss, J.; Gonzato, O.; van der Graaf, W.; Hecker-Nolting, S.; Herrero-Martin, D.; Klco-Brosius, S.; Kovar, H.; Ladenstein, R.; Lancia, C.; LeDeley, M. C.; McCabe, M. G.; Metzler, M.; Myklebost, O.; Nathrath, M.; Picci, P.; Potratz, J.; Redini, F.; Richter, G. H. S.; Reinke, D.; Rutkowski, P.; Scotlandi, K.; Strauss, S.; Thomas, D.; Tirado, O. M.; Tirode, F.; Vassal, G.; Bielack, S. S. |
Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome |
journalArticle |
2015 |
Patrikidou, A.; Brureau, L.; Casenave, J.; Albiges, L.; Di Palma, M.; Patard, J. J.; Baumert, H.; Blanchard, P.; Bossi, A.; Kitikidou, K.; Massard, C.; Fizazi, K.; Blanchet, P.; Loriot, Y. |
Precision medicine for metastatic breast cancer--limitations and solutions |
journalArticle |
2015 |
Arnedos, M.; Vicier, C.; Loi, S.; Lefebvre, C.; Michiels, S.; Bonnefoi, H.; Andre, F. |
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues |
journalArticle |
2016 |
Martelli, N.; van den Brink, H.; Borget, I. |
[Does sentinel lymph node identification has indication in digestive cancers?] |
journalArticle |
2019 |
Faron, M.; Laas, E. |
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation |
journalArticle |
2018 |
Frank, S. J.; Blanchard, P.; Lee, J. J.; Sturgis, E. M.; Kies, M. S.; Machtay, M.; Vikram, B.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Hutcheson, K.; Lai, S.; Busse, P. M.; Lee, N. Y.; Lin, A.; Foote, R. L. |
Bevacizumab versus anti-epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block? |
journalArticle |
2016 |
Ducreux, M.; Pignon, J. P. |
Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells |
journalArticle |
2016 |
Mittal, D.; Caramia, F.; Michiels, S.; Joensuu, H.; Kellokumpu-Lehtinen, P. L.; Sotiriou, C.; Loi, S.; Smyth, M. J. |
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial |
journalArticle |
2015 |
van den Berg, H.; Paulussen, M.; Le Teuff, G.; Judson, I.; Gelderblom, H.; Dirksen, U.; Brennan, B.; Whelan, J.; Ladenstein, R. L.; Marec-Berard, P.; Kruseova, J.; Hjorth, L.; Kuhne, T.; Brichard, B.; Wheatley, K.; Craft, A.; Juergens, H.; Gaspar, N.; Le Deley, M. C.; Euro, Ewing Group |
Incorporation of nested frailties into semiparametric multi-state models |
journalArticle |
2016 |
Rotolo, F.; Rondeau, V.; Legrand, C. |
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort |
journalArticle |
2018 |
Kandel, M.; Allayous, C.; Dalle, S.; Mortier, L.; Dalac, S.; Dutriaux, C.; Leccia, M. T.; Guillot, B.; Saiag, P.; Lacour, J. P.; Legoupil, D.; Lesimple, T.; Aubin, F.; Beylot-Barry, M.; Brunet-Possenti, F.; Arnault, J. P.; Granel-Brocard, F.; Stoebner, P. E.; Dupuy, A.; Maubec, E.; Grob, J. J.; Dreno, B.; Rotolo, F.; Ballon, A.; Michiels, S.; Lebbe, C.; Borget, I. |
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification |
journalArticle |
2017 |
Andreiuolo, F.; Le Teuff, G.; Bayar, M. A.; Kilday, J. P.; Pietsch, T.; von Bueren, A. O.; Witt, H.; Korshunov, A.; Modena, P.; Pfister, S. M.; Pagès, M.; Castel, D.; Giangaspero, F.; Chimelli, L.; Varlet, P.; Rutkowski, S.; Frappaz, D.; Massimino, M.; Grundy, R.; Grill, J. |